Urine Drug Testing in Chronic Pain: A Patient Centered Approach
June 25, 2013 1:00 pm - 2:00 pm ET
Prescribers’ Clinical Support System for Opioid Therapies (PCSS-O) is a three year grant funded by Substance Abuse and Mental Health Services Administration (SAMHSA),Center for Substance Abuse Treatment (CSAT). It is a collaborative project led by American Academy of Addiction Psychiatry (AAAP) with: American Dental Association (ADA), American Medical Association (AMA), American Osteopathic Academy of Addiction Medicine (AOAAM), American Psychiatric Association (APA), American Society for Pain Management Nursing (ASPMN), and International Nurses Society on Addictions (IntNSA). These organizations are providing training and education on the safe and effective prescribing of opioid medications in the treatment of pain and/or opioid addiction.
A webinar offered by American Medical Association (AMA).
This webinar will provide an overview of the benefits and limitations of urine drug testing in patients with chronic pain. It is intended to provide clinicians with knowledge that will facilitate incorporation of urine drug testing into their practice, with an emphasis on its use as a safety and monitoring tool.
- Describe clinical guidelines on appropriate use of urine drug testing (UDT) in the management of patient with chronic pain.
- Differentiate between the use of UDT for monitoring adherence to therapy and for detection of aberrant drug-related behaviors.
- Formulate practice strategies for appropriate testing, accurate interpretation, and enhanced clinical utility of UDT results.
Date: June 25, 2013
Speaker: Douglas L. Gourlay, MD, FRCPC, FASAM The Wasser Pain Management Centre
Mount Sinai Hospital Toronto, Ontario
Time: 1:00 pm – 2:00 pm ET
To Register: http://eo2.commpartners.com/users/ama/session.php?id=11045
Funding for this initiative was made possible (in part) by Prescribers’ Clinical Support System for Opioid Therapies (1H79TI023439) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reﬂect the ofﬁcial policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.